Wanxiang-backed Hello Heart, the developer of a home blood pressure-monitoring system, collected $12m in a round led by Khosla Ventures.
Hello Heart, an Israel-based medical monitoring technology developer backed by automotive components manufacturer Wanxiang, has raised $12m in funding, VentureBeat reported on Tuesday.
The round was led by venture capital firm Khosla Ventures and also featured fellow VC firms BlueRun Ventures, Maven Ventures and Resolute Ventures.
Hello Heart is the creator of an in-home blood pressure monitor that allows users to self-manage hyperextension.
The company’s mobile app keeps track of users’ blood sugar, weight and activity, offering personalised advice on…
